Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Xavier Castells, Thomas R. Kosten, Dolors Capellà, Xavier Vidal, Joan Colom & Miguel Casas. (2009) Efficacy of Opiate Maintenance Therapy and Adjunctive Interventions for Opioid Dependence with Comorbid Cocaine Use Disorders: A Systematic Review and Meta-Analysis of Controlled Clinical Trials. The American Journal of Drug and Alcohol Abuse 35:5, pages 339-349.
Read now
Read now
EdwardB. Perry, Roberto Gil, Deborah Miles, Louise Brenner, Lisa Macdougall, Robin Johnson, Kathleen Degen, Ralitza Gueorguieva, IsmeneL. Petrakis, JohnH. Krystal & D.
Cyril D'Souza. (2005) Mazindol Augmentation of Antipsychotic Treatment for Schizophrenic Patients with Comorbid Cocaine Abuse or Dependence. Journal of Dual Diagnosis 1:1, pages 37-47.
Read now
Read now
Tony P George, Therese A Kosten & Thomas R Kosten. (2002) The potential of dopamine agonists in drug addiction. Expert Opinion on Investigational Drugs 11:4, pages 491-499.
Read now
Read now
Kathleen M Carroll. (2000) Implications of Recent Research for Program Quality in Cocaine Dependence Treatment. Substance Use & Misuse 35:12-14, pages 2011-2030.
Read now
Read now
Arthur Margolin, S. Kelly Avants, RobertT. Malison & ThomasR. Kosten. (1997) High‐ and low‐dose Mazindol for cocaine dependence in methadone‐maintained patients: A preliminary evaluation. Substance Abuse 18:3, pages 125-131.
Read now
Read now
Arthur Margolin, S.
Kelly Avants, Bruce Rounsaville, ThomasR. Kosten & RichardS. Schottenfeld. (1997) Motivational Factors in Cocaine Pharmacotherapy Trials with Methadone-Maintained Patients: Problems and Paradoxes. Journal of Psychoactive Drugs 29:2, pages 205-212.
Read now
Read now
Arthur Margolin, S.
Kelly Avants & ThomasR. Kosten. (1996) Pemoline for the Treatment of Cocaine Dependence in Methadone-Maintained Patients. Journal of Psychoactive Drugs 28:3, pages 301-304.
Read now
Read now
Articles from other publishers (39)
Brian Chan, Michele Freeman, Chelsea Ayers, P. Todd Korthuis, Robin Paynter, Karli Kondo & Devan Kansagara. (2020) A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders. Drug and Alcohol Dependence 216, pages 108193.
Crossref
Crossref
Xavier Castells, Ruth Cunill, Clara Pérez-Mañá, Xavier Vidal & Dolors Capellà. (2016) Psychostimulant drugs for cocaine dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Matthew L. Banks, Blake A. Hutsell, Kathryn L. Schwienteck & S. Stevens Negus. (2015) Use of Preclinical Drug Vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction. Current Treatment Options in Psychiatry 2:2, pages 136-150.
Crossref
Crossref
Kevin A. Sevarino & Bryan C. Shelby. 2015. Psychiatry. Psychiatry
1561
1614
.
David J. Heal, Jane Gosden & Sharon L. Smith. (2014) Dopamine reuptake transporter (DAT) “inverse agonism” – A novel hypothesis to explain the enigmatic pharmacology of cocaine. Neuropharmacology 87, pages 19-40.
Crossref
Crossref
John J. Mariani & Frances R. Levin. (2012) Psychostimulant Treatment of Cocaine Dependence. Psychiatric Clinics of North America 35:2, pages 425-439.
Crossref
Crossref
Clara Pérez-Mañá, Xavier Castells, Xavier Vidal, Miguel Casas & Dolors Capellà. (2011) Efficacy of indirect dopamine agonists for psychostimulant dependence: A systematic review and meta-analysis of randomized controlled trials. Journal of Substance Abuse Treatment 40:2, pages 109-122.
Crossref
Crossref
Xavier Castells, Miguel Casas, Clara Pérez-Mañá, Carlos Roncero, Xavier Vidal & Dolors Capellà. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Bernardo Soares, Anelise ARL Lima Reisser, Michael Farrell & Mauricio Silva de Lima. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
John D. Roache. 2011. Addiction Medicine. Addiction Medicine
129
157
.
Didier Jutras-AswadM.D. M. ScM.D. M. Sc, Julie BruneauM.D. M. ScM.D. M. Sc & Yasmin L. HurdPh. D.Ph. D.. (2010) Neurobiologie de la toxicomanie : avancées récentes et nouvelles stratégies d’intervention. Drogues, santé et société 8:2, pages 27-73.
Crossref
Crossref
F. Gerard Moeller, Joy M. Schmitz, David Herin & Kimberly L. Kjome. (2008) Use of stimulants to treat cocaine and methamphetamine abuse. Current Psychiatry Reports 10:5, pages 385-391.
Crossref
Crossref
E. Ambrosio Flores. (2008) Efectos de la cocaína en el ser humano. Trastornos Adictivos 10:3, pages 151-165.
Crossref
Crossref
Tracie J. Gardner, Therese A. Kosten & Thomas R. Kosten. 2008. Animal and Translational Models for CNS Drug Discovery. Animal and Translational Models for CNS Drug Discovery
41
57
.
Xavier Castells, Miguel Casas, Xavier Vidal, Rosa Bosch, Carlos Roncero, Josep Antoni Ramos‐Quiroga & Dolors Capellà. (2007) Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta‐analysis of randomized controlled clinical trials. Addiction 102:12, pages 1871-1887.
Crossref
Crossref
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction
171
243
.
Heath D. Schmidt & R. Christopher Pierce. (2006) Systemic administration of a dopamine, but not a serotonin or norepinephrine, transporter inhibitor reinstates cocaine seeking in the rat. Behavioural Brain Research 175:1, pages 189-194.
Crossref
Crossref
Mehmet Sofuoglu & Thomas R Kosten. (2005) Novel Approaches to the Treatment of Cocaine Addiction. CNS Drugs 19:1, pages 13-25.
Crossref
Crossref
Patricia A Broderick, Opeyemi A Olabisi, David N Rahni & Yueping Zhou. (2004) Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28:3, pages 547-557.
Crossref
Crossref
Tom Waller & Daphne Rumball. 2004. Treating Drinkers and Drug Users in the Community. Treating Drinkers and Drug Users in the Community
409
448
.
Patricia A Broderick, Omotola Hope, Catherine Okonji, David N Rahni & Yueping Zhou. (2004) Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28:1, pages 157-171.
Crossref
Crossref
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse
139
199
.
David H. Epstein & Kenzie L. Preston. (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology 168:1-2, pages 31-41.
Crossref
Crossref
Bernardo Soares, Anelise ARL Lima Reisser, Michael Farrell & Maurício Silva de Lima. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Atapol Sughondhabirom & Robert Malison. 2003. Dopamine Receptors and Transporters. Dopamine Receptors and Transporters
571
588
.
William J. Houlihan & Lawrence Kelly. (2003) Assessment of mazindane, a pro-drug form of mazindol, in assays used to define cocaine treatment agents. European Journal of Pharmacology 458:3, pages 263-273.
Crossref
Crossref
William J. Houlihan, Lawrence Kelly, Jessica Pankuch, Judith Koletar, Leonard Brand, Aaron Janowsky & Theresa A. Kopajtic. (2002) Mazindol Analogues as Potential Inhibitors of the Cocaine Binding Site at the Dopamine Transporter. Journal of Medicinal Chemistry 45:19, pages 4097-4109.
Crossref
Crossref
Santosh S. Kulkarni, Amy Hauck Newman & William J. Houlihan. (2002) Three-Dimensional Quantitative Structure−Activity Relationships of Mazindol Analogues at the Dopamine Transporter. Journal of Medicinal Chemistry 45:19, pages 4119-4127.
Crossref
Crossref
Maurício Silva de Lima, Bernardo Garcia de Oliveira Soares, Anelise Alves Pereira Reisser & Michael Farrell. (2002) Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97:8, pages 931-949.
Crossref
Crossref
Susan M Stine, Steven M Southwick, Ismene L Petrakis, Thomas R Kosten, Dennis S Charney & John H Krystal. (2002) Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biological Psychiatry 51:8, pages 642-651.
Crossref
Crossref
EVARISTO O. AKERELE & FRANCES R. LEVIN. (2002) Substance Abuse Among Patients with Schizophrenia. Journal of Psychiatric Practice 8:2, pages 70-80.
Crossref
Crossref
James A. Halikas, Bruce A. Center, Victoria L. Pearson, Gregory A. Carlson & Fredrick Crea. (2001) A pilot, open clinical study of depakote in the treatment of cocaine abuse. Human Psychopharmacology: Clinical and Experimental 16:3, pages 257-264.
Crossref
Crossref
DAVID C.S. ROBERTS & KAREN BREBNER. (2006) GABA Modulation of Cocaine Self-Administration. Annals of the New York Academy of Sciences 909:1, pages 145-158.
Crossref
Crossref
KEVIN A. SEVARINO, ALISON OLIVETO & THOMAS R. KOSTEN. (2006) Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development. Annals of the New York Academy of Sciences 909:1, pages 51-87.
Crossref
Crossref
Sharon M. Hall, David A. Wasserman, Barbara E. Havassy & Peg Maude-Griffin. 1998. Cocaine Abuse. Cocaine Abuse
389
407
.
Maxine L Stitzer & Sharon L Walsh. (1997) Psychostimulant Abuse: The Case for Combined Behavioral and Pharmacological Treatments. Pharmacology Biochemistry and Behavior 57:3, pages 457-470.
Crossref
Crossref
Lisa Borg. (1997) Pharmacological therapies for substance dependence. Current Opinion in Psychiatry 10:3, pages 225-229.
Crossref
Crossref
William J. Houlihan, John W. Boja, Vincent A. Parrino, Theresa A. Kopajtic & Michael J. Kuhar. (1996) Halogenated Mazindol Analogs as Potential Inhibitors of the Cocaine Binding Site at the Dopamine Transporter. Journal of Medicinal Chemistry 39:25, pages 4935-4941.
Crossref
Crossref
Arthur Margolin, Thomas R. Kosten, S.Kelly Avants, Jeffery Wilkins, Walter Ling, Mace Beckson, Isabelle O. Arndt, James Cornish, John A. Ascher, Shou-Hua Li & Peter Bridge. (1995) A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug and Alcohol Dependence 40:2, pages 125-131.
Crossref
Crossref